Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector’s diagnostics and research industry, offers an intriguing proposition for investors seeking exposure to the healthcare diagnostics market. With..
Castle Biosciences, Inc. (CSTL), a prominent player in the molecular diagnostics sector, is offering a promising prospect for investors, with an analyst consensus indicating a potential upside of 96.36%. Headquartered..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to treating diseases with significant..
Community Health Systems, Inc. (NYSE: CYH) operates at the heart of the U.S. healthcare sector, providing a broad spectrum of medical services through its general acute care hospitals. Despite the..
Immatics N.V. (NASDAQ: IMTX), a pioneering force in the biotechnology sector, is capturing the attention of investors with its cutting-edge T cell redirecting immunotherapies aimed at revolutionizing cancer treatment. As..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a key player in the biotechnology sector, focusing on the development of genetic therapies for rare and devastating diseases. The company’s innovative approach and..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its cutting-edge approach to drug discovery. With a market capitalization of $1.81..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its innovative approach to cancer treatment. Focused on developing and commercializing oncolytic..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a commercial-stage biopharmaceutical company based in Brisbane, California, is making waves in the biotechnology sector with an impressive 83.9% revenue growth. Specializing in the..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology industry, is capturing the attention of investors with its promising drug pipeline and a significant potential upside of 58.63%...
Neuropace, Inc. (NASDAQ: NPCE), a key player in the healthcare sector, specifically within the medical devices industry, is catching investor attention with a compelling potential upside of 45.50%. Headquartered in..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is currently making waves in the biotechnology industry. With a robust market capitalization of $1.52 billion,..
Investors with an eye on Cronos Group Inc. (NASDAQ: CRON) are witnessing an intriguing narrative unfold in the burgeoning cannabis sector. As a key player in the healthcare industry, specifically..
Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices industry, has been capturing investor attention with its promising potential upside of 34.04%. Headquartered in Burlington, Massachusetts, the..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector with its promising outlook for investors. With a market capitalization of $1.52 billion, Iovance is positioned at the..
Evolus, Inc. (NASDAQ: EOLS) is a name that might not instantly ring a bell for every investor, yet it has carved a niche for itself within the vibrant healthcare sector,..
Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers investors a unique blend of opportunities and challenges. With a market capitalization of $644.13 million, this..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company rooted in the heart of San Diego, California, is capturing the attention of investors with its robust pipeline and impressive growth metrics...
